Home / AJANTPHARM.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does AJANTPHARM.NS make money? Does AJANTPHARM.NS have pricing power? What's the Earnings Whisper? Will AJANTPHARM.NS profit more as the business scales? What is AJANTPHARM.NS's management track record? Is AJANTPHARM.NS's current price justified?

Ajanta Pharma Limited

₹3329 +$390.60 (+13.29%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹3359.4

Day Range

₹3309₹3381

Year Range

₹2382₹3796

Market Cap

415.99B

AVG Volume

107.33K

Trailing/Forward PE

36.65/28.74

PEG ratio

2.59

Dividend Yield

1.80%

Next Earnings Date

2026-10-30

Primary Exchange

National Stock Exchange of India

Revenue (INR) · TTM

AJANTPHARM.NS Revenue (INR) by quarter, trailing twelve months
Period	Revenue (INR)
27 Q1	57.76B
26 Q4	54.53B
26 Q3	51.41B
26 Q2	49.12B
26 Q1	47.45B
25 Q4	45.88B
25 Q3	44.85B
25 Q2	44.44B
25 Q1	42.85B
24 Q4	41.62B

Net Income (INR) · TTM

AJANTPHARM.NS Net Income (INR) by quarter, trailing twelve months
Period	Net Income (INR)
27 Q1	11.35B
26 Q4	10.56B
26 Q3	10.15B
26 Q2	9.74B
26 Q1	9.3B
25 Q4	9.2B
25 Q3	8.98B
25 Q2	8.75B
25 Q1	8.54B
24 Q4	8.16B

Operating Income (INR) · TTM

AJANTPHARM.NS Operating Income (INR) by quarter, trailing twelve months
Period	Operating Income (INR)
27 Q1	21.81B
26 Q4	24.54B
26 Q3	20.07B
26 Q2	18.8B
26 Q1	21.84B
25 Q4	20.6B
25 Q3	20.29B
25 Q2	19.87B
25 Q1	13.58B
24 Q4	13.21B

EBITDA · TTM

Cash Flows · TTM

EPS · TTM

Expenses · TTM

Cash & Debt · TTM

Debt ratios · TTM

Margins · TTM

Return on Capital · TTM

Shares Outstanding · TTM

Dividends (INR) · TTM

Employee Count

Book Value Per Share · TTM

Total Assets · TTM

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Ajanta Pharma Limited

Video analysis: AJANTPHARM.NS

News: AJANTPHARM.NS

Similar companies